|
|
Volumn 35, Issue 5, 2013, Pages 683-687
|
|
Erratum to Comparison of the prevalence of convulsions associated with the use of cefepime and meropenem (Int J Clin Pharm, (2013), 35, (683-687), 10.1007/s11096-013-9799-3);Comparison of the prevalence of convulsions associated with the use of cefepime and meropenem
|
|
Author keywords
Brain disorder; Cefepime; Convulsion; Meropenem; Renal function
|
|
Indexed keywords
AMPHOTERICIN B;
CEFEPIME;
CLONAZEPAM;
CYTARABINE;
DIAZEPAM;
MEROPENEM;
METHOTREXATE;
MORPHINE;
PHENYTOIN;
THIAMYLAL;
TRAMADOL;
ZONISAMIDE;
ADULT;
AGED;
ARTICLE;
BRAIN DISEASE;
CLONIC SEIZURE;
CONSCIOUSNESS DISORDER;
CONSCIOUSNESS LEVEL;
CONTROLLED STUDY;
CONVULSION;
DRUG DOSE INCREASE;
DRUG WITHDRAWAL;
FEMALE;
GLOMERULUS FILTRATION RATE;
HUMAN;
JAPAN;
MAJOR CLINICAL STUDY;
MALE;
MYOCLONUS;
PREVALENCE;
PRIORITY JOURNAL;
RETROSPECTIVE STUDY;
SIDE EFFECT;
TONIC CLONIC SEIZURE;
UNIVERSITY HOSPITAL;
ADULT;
AGED;
ANTI-BACTERIAL AGENTS;
BRAIN DISEASES;
CEPHALOSPORINS;
FEMALE;
HOSPITALS, UNIVERSITY;
HUMANS;
INFUSIONS, INTRAVENOUS;
JAPAN;
MALE;
NEUROTOXICITY SYNDROMES;
PREVALENCE;
PSEUDOMONAS AERUGINOSA;
PSEUDOMONAS INFECTIONS;
RENAL INSUFFICIENCY;
RETROSPECTIVE STUDIES;
RISK;
SEIZURES;
STAPHYLOCOCCAL INFECTIONS;
STAPHYLOCOCCUS AUREUS;
THIENAMYCINS;
|
|
EID: 84886085533
PISSN: 22107703
EISSN: 22107711
Source Type: Journal
DOI: 10.1007/s11096-015-0079-2 Document Type: Erratum |
|
Times cited : (21)
|
|
References (9)
|
